-
公开(公告)号:US12239141B2
公开(公告)日:2025-03-04
申请号:US15549355
申请日:2016-02-10
Applicant: Chr. Hansen A/S
Inventor: Sylvain Brocheret , Marc Faiveley , Jean-Paul Poignand , Sebastien Roustel
IPC: A23C19/032 , A23C19/05 , A23C19/068
Abstract: The invention relates to a method for treatment of milk which is to be used in the preparation of soft cheese, the method comprises adding, practically simultaneously a slow acidifying bacterial culture, a fast acidifying bacterial culture and at least one coagulant. Preferred is a soft-cheese type, such as e.g. a brie type or a camembert type cheese.
-
公开(公告)号:US20250019643A1
公开(公告)日:2025-01-16
申请号:US18713292
申请日:2022-11-28
Applicant: Chr. Hansen A/S
Inventor: Pravin GADKARI , Furqan ALI , Surender Kumar DHAYAL , Deepak JAIN
Abstract: The present invention relates to encapsulation of microbial cultures to improve the robustness and stability upon storage. In particular, the present invention relates to dry preparations of microbial cultures, such as lactic acid bacteria (LAB), coated by a fat-matrix that increase survivability and mitigate post-acidification upon storage at ambient temperature for extended periods of time.
-
公开(公告)号:US20240417765A1
公开(公告)日:2024-12-19
申请号:US18549668
申请日:2022-03-10
Applicant: Chr. Hansen A/S
Inventor: Maria Elina Sundberg , Vojislav Vojinovic , Hans Raj
Abstract: The present invention relates to a fermented milk-based product comprising a combination of low levels of lactose and stable levels of galacto-oligosaccharides (GOS) produced in-situ and methods thereof.
-
公开(公告)号:US20240368533A1
公开(公告)日:2024-11-07
申请号:US18687536
申请日:2022-08-30
Applicant: Chr. Hansen A/S
Inventor: Zuzana Mladenovska , Birgitte Yde , Hans Bisgaard-Frantzen
Abstract: The present invention relates to the provision of methods of preparing a bacterial culture and bacterial cultures obtained thereby. The present invention also relates to the provision of methods for reducing viability loss and/or activity loss during freezing and/or drying of a bacterial culture and for increasing storage stability of a frozen and/or dried bacterial culture.
-
公开(公告)号:US20240287565A1
公开(公告)日:2024-08-29
申请号:US18546949
申请日:2022-02-22
Applicant: Chr. Hansen A/S
Inventor: Vojislav VOJINOVIC , Kim Ib SOERENSEN , Laurent GUINOT
CPC classification number: C12P19/12 , A23C9/1238 , C12N1/20 , C12N9/1205 , C12R2001/46 , C12Y207/01002 , C12Y207/01006
Abstract: The invention relates to a method of obtaining a composition comprising allolactose by a applying one or more glucose-deficient lactic acid bacteria strains. The invention also relates to the use of said strains for the preparation of a food product comprising allolactose and to the use of said strains for increasing the content of allolactose in a food product. The invention also relates to a food product comprising allolactose and one or more glucose-deficient lactic acid bacteria strains.
-
6.
公开(公告)号:US20240237663A1
公开(公告)日:2024-07-18
申请号:US18559720
申请日:2022-05-05
Applicant: Chr. Hansen A/S
Inventor: Victoria Prebner , Vojislav Vojinovic , Maria Elina Sundberg
CPC classification number: A23C9/1206 , A23C9/1238 , C12N1/205 , C12N9/2402 , C12Y302/01108 , A23V2400/123 , A23V2400/249 , C12R2001/225 , C12R2001/46
Abstract: The present invention is in the field of dairy technology. It relates to a method for producing a fermented milk product comprising the steps: (a) Providing a starter culture comprising one or more lactic acid bacteria strains selected from a group consisting of: DSM 22935, DSM 22585, DSM 22586, DSM28910 and DSM33677; (b) Adding the starter culture to a milk base to ferment said milk base until a target pH is reached; and (c) Adding a lactase to the milk base; wherein the fermented milk product has improved texture and/or reduced post-acidification as compared to a fermented milk product produced without addition of the lactase of step c) or the starter culture of step a).
-
公开(公告)号:US20240229093A1
公开(公告)日:2024-07-11
申请号:US18562047
申请日:2021-05-20
Applicant: Chr. Hansen A/S
Inventor: Katja Parschat , Stefan Jennewein
IPC: C12P19/26 , C12N1/16 , C12N1/20 , C12N9/10 , C12R1/07 , C12R1/185 , C12R1/78 , C12R1/84 , C12R1/85
CPC classification number: C12P19/26 , C12N1/16 , C12N1/20 , C12N9/1051 , C12N2500/34 , C12R2001/07 , C12R2001/185 , C12R2001/78 , C12R2001/84 , C12R2001/85 , C12Y204/0109
Abstract: Disclosed is a process for the production of a desired oligosaccharide, the process comprises providing a genetically engineered microbial cell which possesses a saccharide importer for the uptake of an intermediate oligosaccharide, and an enzyme being able to convert the intermediated oligosaccharide by transferring a monosaccharide moiety from a donor substrate to the intermediate oligosaccharide; cultivating the genetically engineered microbial cell in the presence of an intermediate oligosaccharide to generate the desired oligosaccharide; and retrieving the desired oligosaccharide.
-
公开(公告)号:US20240132832A1
公开(公告)日:2024-04-25
申请号:US18254658
申请日:2021-11-29
Applicant: Chr. Hansen A/S
Inventor: Zuzana Mladenovska , Surender Kumar Dhayal , Kim Nielsen
Abstract: The present invention relates to the field of frozen or dry compositions for prokaryotes, in particular fermentative bacteria such as lactic acid bacteria, a method for preparing frozen or dry prokaryotic compositions and compositions which may be prepared by said method. The cells in a cell concentrate are activated by allowing them to ferment a carbohydrate, before freezing and/or drying to provide a product. The hydrophobicity of the cell surface increases during activation, and this has been found to increase the storage stability of the product.
-
9.
公开(公告)号:US20230149484A1
公开(公告)日:2023-05-18
申请号:US18147948
申请日:2022-12-29
Applicant: Chr. Hansen A/S
Inventor: Pravas Ranjan Misra
IPC: A61K35/747 , A61K9/00 , A61K31/702
CPC classification number: A61K35/747 , A61K9/0029 , A61K9/0053 , A61K31/702
Abstract: The present invention provides a pharmaceutical composition including a probiotic and a prebiotic for treatment of stunting in children. More particularly, the pharmaceutical composition includes at least one Lactobacillus specie(s) as a probiotic and at least one oligosaccharide as a prebiotic. The present invention further provides a method of treatment of stunting including administering an effective amount of a pharmaceutical composition including a probiotic and a prebiotic to children in need thereof.
-
10.
公开(公告)号:US11540527B2
公开(公告)日:2023-01-03
申请号:US16061638
申请日:2016-12-16
Applicant: Chr. Hansen A/S
Inventor: Gaelle Lettier Buchhorn , Kim Ib Soerensen , Mette Pia Junge
IPC: A23C9/123
Abstract: The present invention relates to a Streptococcus thermophilus strain, wherein the strain is galactose-fermenting, wherein the strain carries a mutation in the DNA sequence of the glcK gene encoding a glucokinase protein, wherein the mutation inactivates the glucokinase protein or has a negative effect on expression of the gene, and wherein the strain carries a mutation in the promoter region of the GalK gene encoding a galactokinase protein.
-
-
-
-
-
-
-
-
-